ResearcherSecond Military Medical UniversityActive in the last 2 years
Zhuan Liao
Matched on ORCID iD 0000-0001-8506-8159; OpenAlex author ID A5041954083. Sources: ClinicalTrials.gov.
Their work
- Papers
- 7 (first author 1, last author 2)
- Trials
- 4 (principal investigator on 4)
- Grants
- 0
- Labs led
- 1
- Collaborators
- 30
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper, 1 trial · 2026: 2 papers, 3 trials
Papers 7
- Global, regional, and national burdens of pancreatic cancer and pancreatitis among older adults from 1990 to 2021: A comparative investigation. Co-author DOI 10.1016/j.pan.2026.07.012↗
- Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analy… Last author DOI 10.1016/j.tranon.2026.102674↗
- Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer. Co-author DOI 10.1186/s40246-025-00740-x↗
- SPINK1 mutations and risk of pancreatic cancer in a Chinese cohort. Last author DOI 10.1016/j.pan.2021.05.304↗
- Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2019-318860↗
- Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: A cohort of 1656 patients. Co-author DOI 10.1016/j.dld.2017.07.001↗
- Incidence of pancreatic cancer in chinese patients with chronic pancreatitis. First author DOI 10.1159/000322982↗
Trials 4
- CAR-NK Cells (CL-NK-003) in Pancreatic Cancer Principal investigator NCT07425483↗
- Immune Repertoire Decoding for Chronic Pancreatitis-to-Pancreatic Cancer Risk Stratification Principal investigator NCT07612566↗
- Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancreatitis Principal investigator NCT07762950↗
- CAR-NK Cells (CL-NK-001) in Pancreatic Cancer Principal investigator NCT06816823↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xuetao Cao · 2 shared trials, 2025–2026 · strength 1.75
- Wen‐Bin Zou · 6 shared papers, 2017–2026 · strength 1.22
- Paper Global, regional, and national burdens of pancreatic cancer and pancreatitis among older adults from 1990 to 2021: A co… DOI 10.1016/j.pan.2026.07.012↗
- Paper Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer. DOI 10.1186/s40246-025-00740-x↗
- Paper Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A … DOI 10.1016/j.tranon.2026.102674↗
- Lei Wang · 2 shared papers, 2021–2026 · strength 0.42
- Lei Huang · 1 shared paper, 2026 · strength 0.36
- Zhaoshen Li · 1 shared paper, 2026 · strength 0.36
- Jian‐Min Chen · 1 shared paper, 2025 · strength 0.30
- Qi-Wen Wang · 1 shared paper, 2025 · strength 0.30
- Di Wu · 1 shared paper, 2026 · strength 0.29
- Liang‐Hao Hu · 3 shared papers, 2011–2021 · strength 0.20
- Paper SPINK1 mutations and risk of pancreatic cancer in a Chinese cohort. DOI 10.1016/j.pan.2021.05.304↗
- Paper Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: A cohort of 1656 patients. DOI 10.1016/j.dld.2017.07.001↗
- Paper Incidence of pancreatic cancer in chinese patients with chronic pancreatitis. DOI 10.1159/000322982↗
- Nan Ru · 1 shared paper, 2021 · strength 0.13
- Zhao‐Shen Li · 1 shared paper, 2021 · strength 0.13
- Shulin Yu · 1 shared paper, 2020 · strength 0.09
- Shenglin Huang · 1 shared paper, 2020 · strength 0.09
- Zhen Chen · 1 shared paper, 2020 · strength 0.09
- Peng Wang · 1 shared paper, 2020 · strength 0.09
- Ling Mei Qian · 1 shared paper, 2020 · strength 0.09
- Zhiqiang Meng · 1 shared paper, 2020 · strength 0.09
- Yuchen Li · 1 shared paper, 2020 · strength 0.09
- Zheng Wang · 1 shared paper, 2020 · strength 0.09
- Ya‐Wei Bi · 1 shared paper, 2017 · strength 0.05
- Bai‐Rong Li · 1 shared paper, 2017 · strength 0.05
- Zhao‐Shen Li · 1 shared paper, 2017 · strength 0.05
- Lu Hao · 1 shared paper, 2017 · strength 0.05
- Jie Chen · 1 shared paper, 2011 · strength 0.02
- Luo‐Wei Wang · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.